Compositions of polysaccharides derived from heparin, their...

Details Compositions of polysaccharides derived from heparin, their... Compositions of polysaccharides derived from heparin, their...

2005-04-01

2010-10-12

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S021000

Reexamination Certificate

active

07812007

ABSTRACT:
Alkali and alkali-earth metal salts of polysaccharides derived from heparin, their method of preparation and the pharmaceutical compositions containing them.

REFERENCES:
patent: 4168377 (1979-09-01), Choay et al.
patent: 4401662 (1983-08-01), Lormeau et al.
patent: 4401758 (1983-08-01), Lormeau et al.
patent: 4440926 (1984-04-01), Mardiguian et al.
patent: 4474770 (1984-10-01), Lormeau et al.
patent: 4500519 (1985-02-01), Lormeau et al.
patent: 4533549 (1985-08-01), Lasker
patent: 4686288 (1987-08-01), Lormeau et al.
patent: 4826827 (1989-05-01), Lormeau et al.
patent: 4981955 (1991-01-01), Lopez
patent: 4987222 (1991-01-01), DeAmbrosi et al.
patent: 5380716 (1995-01-01), Conrad et al.
patent: 5389618 (1995-02-01), Debrie
patent: 5576304 (1996-11-01), Kakkar et al.
patent: RE35770 (1998-04-01), Lormeau et al.
patent: 6001820 (1999-12-01), Hirsh et al.
patent: 6075013 (2000-06-01), Weitz et al.
patent: 6103705 (2000-08-01), Uzan et al.
patent: 6197943 (2001-03-01), Casu et al.
patent: 6384021 (2002-05-01), Mardiguian
patent: RE38743 (2005-06-01), Debrie
patent: 2004/0171819 (2004-09-01), Viskov
patent: 2005/0090561 (2005-04-01), Laux et al.
patent: 2008/0182820 (2008-07-01), Viskov
patent: B-70519/81 (1981-11-01), None
patent: 0 027 089 (1981-04-01), None
patent: 0 037 319 (1981-10-01), None
patent: 0 040 144 (1981-11-01), None
patent: 0114589 (1984-01-01), None
patent: 0 114 589 (1984-08-01), None
patent: 0 293 539 (1988-12-01), None
patent: 1 070 503 (2001-01-01), None
patent: 2 077 533 (1995-11-01), None
patent: 2 663 639 (1991-12-01), None
patent: WO 81 02737 (1981-10-01), None
patent: WO 98/55515 (1998-12-01), None
patent: WO 02/08295 (2002-01-01), None
English language Derwent abstract of EP 0 040 144 A1.
English language Derwent abstract of EP 0 037 319 A1.
English language Derwent abstract of FR 2 663 639 A1.
English language Derwent abstract of EP 0 027 089 A1.
English language Derwent abstract of ES 2 077 533 A1.
English language Derwent abstract of WO 81 02737 A1.
Barrowcliffe et al., Thromb. Res., 12(1): 27-36 (1977).
D.A. Lane et al., Thromb. Res., 12(2): 257-271 (1978).
Teien et al., Thromb. Res., 10(3): 399-410 (1977).
Andersson L.O. et al., Thromb. Res., 15(3/4): 531-541 (1979).
R. Schwesinger et al., Angew. Chem. Int. Ed. Engl. 26(11): 1167-1169 (1987).
R. Schwesinger et al., Angew. Chem. 105(9): 1420 (1993).
Chemical Abstracts Service, Vila Phai, F. Javier et al., “Preparation of saccharide oligomers by chemical depolymerization of heparin derivatives,” database accession No. 125:303695 CA XP002165195.
Galezowski, W. et al, “Homoconjugated Hydrogen Bonds with Amidine and Guanidine Bases, Osmometric, Potentiometric and FTIR Studies,” J. Chem. Soc., Faraday Transactions, 93(15): 2515-2518 (1997).
International Search Report mailed Dec. 6, 2001, for PCT Application No. PCT/FR01/02332, filed Jul. 18, 2001 (4 pages).
Declaration Pursuant to 37 C.F.R. § 1.132 of Dr. Christian Viskov, for reissue U.S. Appl. No. 10/430,435, filed May 7, 2003, including attached Tables 1(a), 1(b), and 2 (8 pages total).
Letter by a third party, Ungria Patentes Y Marcas, S.A. of Madrid, Spain, to the European Patent Office during the examination of the EPO Application No. 01955436.9.
Office Action dated Aug. 29, 2007, in U.S. Appl. No. 10/899,618.
Office Action dated Jun. 5, 2008, in U.S. Appl. No. 10/899,618.
English language Derwent abstract of EP 0 293 539 A2.
Barrowcliffe, T.W., et al., “An International Standard for Low Molecular Weight Heparin,” Thrombosis and Haemostasis, National Institute for Biological Standards and Control, UK, 60(1), pp. 1-7, 1988.
Barrowcliffe, T.W., et al., “Standardization of Low Molecular Weight Heparins: A Collaborative Study,” Thrombosis and Haemostasis, National Institute for Biological Standards and Control, London, 54(3), pp. 675-679, 1985.
Choay, J., et al., “Structural Studies on A Biologically Active Hexasaccharide Obtained from Heparin,” NYAS, pp. 644-649, 1981.
Hook et al., “Anticoagulant Activity of Heparin: Separation of High-Activity and Low-Activity Heparin Species by Affinity Chromatography on Immobilized Antithrombin,” Annals of the New York Academy of Sciences, 370, FEBS Letters, vol. 66, No. 1, pp. 90-93, Jul. 1976.
Office Action dated Apr. 19, 2006 in U.S. Appl. No. 10/680,934.
Office Action dated Aug. 9, 2006 in U.S. Appl. No. 10/680,934.

Affiliated with

Also associated with

Rating

Compositions of polysaccharides derived from heparin, their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions of polysaccharides derived from heparin, their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of polysaccharides derived from heparin, their... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4183305